NP-313

CAS No. 5397-78-4

NP-313( —— )

Catalog No. M34006 CAS No. 5397-78-4

NP-313 (NSC-4264) is a potent antithrombotic agent that inhibits platelet aggregation and activation by inhibiting thromboxane A 2 synthesis and selectively inhibiting SOCC-mediated Ca2+ efflux.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 73 In Stock
5MG 116 In Stock
10MG 187 In Stock
25MG 365 In Stock
50MG 542 In Stock
100MG 759 In Stock
500MG 1557 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NP-313
  • Note
    Research use only, not for human use.
  • Brief Description
    NP-313 (NSC-4264) is a potent antithrombotic agent that inhibits platelet aggregation and activation by inhibiting thromboxane A 2 synthesis and selectively inhibiting SOCC-mediated Ca2+ efflux.
  • Description
    NP-313 is a potent antithrombotic agent that inhibits platelet aggregation and activation. NP-313 has dual inhibition of thromboxane A 2 synthesis and selective inhibition of SOCC-mediated Ca2+ inward flow.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Autophagy
  • Target
    Thrombin
  • Recptor
    Thrombin | Calcium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    5397-78-4
  • Formula Weight
    249.65
  • Molecular Formula
    C12H8ClNO3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 25 mg/mL (100.14 mM; Ultrasonic )
  • SMILES
    O=C1C=2C(C(=O)C(Cl)=C1NC(C)=O)=CC=CC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Heng-Lan Kuo, et al. NP-313, 2-acetylamino-3-chloro-1,4-naphthoquinone, a novel antithrombotic agent with dual inhibition of thromboxane A(2) synthesis and calcium entry. Br J Pharmacol. 2011 Apr;162(8):1871-83.??
molnova catalog
related products
  • Argatroban

    Argatroban is a direct, selective thrombin inhibitor.

  • Flovagatran

    Flovagatran (TGN 255) is an orally active, potent, and selective inhibitor of thrombin and parenteral direct factor II.Flovagatran is used to study venous thromboembolism.

  • Dabigatran

    A reversible and selective, direct thrombin inhibitor (DTI) with Ki value of 4.5 nM.